Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia

Biomarker panel for early screening of trastuzumab -induced cardiotoxicity among breast cancer patients in west virginia

Cardiotoxicity is a well-known pathophysiological consequence in breast cancer patients receiving trastuzumab. Trastuzumab related cardiotoxicity typically results in an overall decline in cardiac function, primarily characterized by reduction in left ventricular ejection fraction (LVEF) and develop...

Full description

Bibliographic Details
Main Authors: Sneha S. Pillai, Duane G. Pereira, Gloria Bonsu, Hibba Chaudhry, Nitin Puri, Hari Vishal Lakhani, Maria Tria Tirona, Komal Sodhi, Ellen Thompson
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Pharmacology
Subjects:
Cardiotoxicity after chemotherapy
biomarkers
Cardiac dysfunction
microRNA
breast cancer
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.953178/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.953178/full

Similar Items